Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Net Current Assets

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Net Current Assets History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Current Assets (Including Current Investments) ₹1,322 Cr₹4,446 Cr₹2,461 Cr₹1,780 Cr₹2,526 Cr

What is the latest Net Current Assets ratio of MANKIND PHARMA ?

The latest Net Current Assets ratio of MANKIND PHARMA is ₹1,322 Cr based on Mar2025 Consolidated results.
Year Net Current Assets
Mar2025₹1,322 Cr
Mar2024₹4,446 Cr
Mar2023₹2,461 Cr
Mar2022₹1,780 Cr
Mar2021₹2,526 Cr

How is Net Current Assets of MANKIND PHARMA Trending?

Years Net Current Assets % Change
Mar2025 ₹1,322 Cr
-70.26
Mar2024 ₹4,446 Cr
80.62
Mar2023 ₹2,461 Cr
38.25
Mar2022 ₹1,780 Cr
-29.52
Mar2021 ₹2,526 Cr -

Compare Net Current Assets of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹104,536.5 Cr 1.8% 6.7% 8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,989.0 Cr 1.7% 6.4% 12.1% Stock Analytics
DIVIS LABORATORIES ₹179,471.0 Cr 3% 2.8% 0.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹161,290.0 Cr 2.3% 9.1% 44.6% Stock Analytics
CIPLA ₹117,820.0 Cr 0.3% 6.1% -3.7% Stock Analytics
DR REDDYS LABORATORIES ₹114,730.0 Cr -0.1% 8.9% 1.9% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.8%

6.7%

8%

SENSEX

0.9%

4.2%

-6%


You may also like the below Video Courses